Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30 CA014520
National Institutes of Health
Grant: P50DE026787
National Institutes of Health
Grant: R01-CA163662
National Institutes of Health
Grant: R01-DE028341
NCI NIH HHS
Grant: P30 CA013148
NCI NIH HHS
Grant: R01 CA163662
NIDCR NIH HHS
Grant: R01 DE028341
National Institutes of Health
Grant: 5R01DE028341-02
A kinase-independent role for EGFR in p38MAPK suppression and S-phase progression in head and neck cancer
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5R01CA163662-03
Signaling role of syndecans in HER2+ and triple negative breast cancer
University of Wisconsin Carbone Cancer Center
School of Medicine and Public Health, University of Wisconsin-Madison
FWCI
0.79
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals